Search results
Cure Genetics Announced Promising Safety and Efficacy Data of CAR-NKT Product CGC729 for RCC at...
WKBN 27 Youngstown· 1 day agoOn May 10, 2024, Cure Genetics announced the safety and efficacy data of their CAR-NKT product, CGC729, for patients with relapsed and refractory metastatic renal cell carcinoma ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 21 hours agoSOUTH SAN FRANCISCO, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, ...
Blood test to detect colon cancer could move a step closer to FDA approval in the US
CNN via Yahoo News· 19 hours agoGuardant Health’s Shield tests could be the first approved blood screening test for colorectal...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 19 hours agoSALT LAKE CITY, May 23, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and its collaborators ...
Atossa Genetics Inc. (ATOS) is a Great Momentum Stock: Should You Buy?
Zacks· 4 days agoBelow, we take a look at Atossa Genetics Inc. (ATOS Quick QuoteATOS - Free Report) , which currently has a Momentum Style Score of B. We also discuss some of the main drivers ...
Tracking the cellular and genetic roots of neuropsychiatric disease
Medical Xpress· 23 hours agoThe findings, reported May 23 in Science, were the result of a multi-institutional collaboration...
Challenges overcome, Napa Valley College graduates reflect
Napa Valley Register· 2 hours agoNapa Valley College's Class of 2024 accepted their diplomas Thursday night – after enduring...
Amalgamated Bank Buys 692 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
ETF DAILY NEWS· 6 days agoAmalgamated Bank lifted its stake in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 2.2% in the 4th quarter, according to the company in its most recent filing with ...
New Research Demonstrates the Importance of Genetic Testing for Many Cancers Not Currently Covered...
NBC 10 - FOX 14 Monroe· 20 hours agoInvitae (OTC:NVTAQ), a leading medical genetics company, today announced eight studies to be presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting ...
OPKO Health, Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost Buys 100,000 Shares of Stock
ETF DAILY NEWS· 7 hours agoOPKO Health, Inc. (NASDAQ:OPK – Get Free Report) CEO Phillip Md Et Al Frost acquired 100,000 shares of the firm’s stock in a transaction on Thursday, May 23rd. The stock was purchased at an ...